Skip to main content
SpringerLink
Log in

Dynamic risk stratification system provides a new paradigm to properly manage low-risk papillary thyroid microcarcinoma treated with radiofrequency ablation

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

The Original Article was published on 19 August 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vaccarella S, Lortet-Tieulent J, Colombet M et al (2021) Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol 9:144–152

    Article  PubMed  Google Scholar 

  2. Leboulleux S, Tuttle RM, Pacini F, Schlumberger M (2016) Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol 4:933–942

    Article  PubMed  Google Scholar 

  3. van Dijk SPJ, Coerts HI, Gunput STG et al (2022) Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 148:317–325

    Article  PubMed  PubMed Central  Google Scholar 

  4. Choi Y, Jung SL (2020) Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid 30:720–731

    Article  PubMed  Google Scholar 

  5. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133

    Article  PubMed  PubMed Central  Google Scholar 

  6. Scappaticcio L, Trimboli P, Verburg FA, Giovanella L (2020) Significance of “de novo” appearance of thyroglobulin antibodies in patients with differentiated thyroid cancer. Int J Biol Markers 35(3):41–49

    Article  CAS  PubMed  Google Scholar 

  7. Li X, Yan L, Xiao J et al (2023) Follow-up strategy of radiofrequency ablation for papillary thyroid microcarcinoma: defining a response-to-ablation system. Eur Radiol. https://doi.org/10.1007/s00330-023-10022-6

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ali S, Cibas ES (2018) The Bethesda system for reporting thyroid cytopathology,2nd edn. Springer, Berlin

    Book  Google Scholar 

  9. Tessler FN, Middleton WD, Grant EG et al (2017) ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol 14(5):587–595

    Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Unit of Endocrinology and Metabolic Diseases, AOU University of Campania “Luigi Vanvitelli”, Naples, Italy

    Lorenzo Scappaticcio & Giuseppe Bellastella

  2. Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, 80138, Naples, Italy

    Lorenzo Scappaticcio & Giuseppe Bellastella

Authors
  1. Lorenzo Scappaticcio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Bellastella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorenzo Scappaticcio.

Ethics declarations

Guarantor

The scientific guarantor for this commentary is Lorenzo Scappaticcio.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this commentary.

Informed consent

Not applicable to this commentary.

Ethical approval

Not applicable to this commentary.

Methodology

• commentary

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-10022-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scappaticcio, L., Bellastella, G. Dynamic risk stratification system provides a new paradigm to properly manage low-risk papillary thyroid microcarcinoma treated with radiofrequency ablation. Eur Radiol 34, 758–760 (2024). https://doi.org/10.1007/s00330-023-10113-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-10113-4

Search

Navigation